| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/01/2003 | WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 05/01/2003 | WO2002099388A3 Benzodiazepine bradykinin antagonists |
| 05/01/2003 | WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
| 05/01/2003 | WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase |
| 05/01/2003 | WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/01/2003 | WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083369 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity |
| 05/01/2003 | US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 05/01/2003 | US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole |
| 05/01/2003 | US20030083336 Dopamine D4 receptor ligands; treating psychosis, schizophrenia and affective disorders |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment |
| 05/01/2003 | US20030083268 Isoquinoline compounds having antiinfective activity |
| 05/01/2003 | US20030082330 High density recording |
| 05/01/2003 | US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 05/01/2003 | CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 05/01/2003 | CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds |
| 05/01/2003 | CA2464561A1 Methods of treatment using a gastric retained losartan dosage |
| 05/01/2003 | CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 05/01/2003 | CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 05/01/2003 | CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 05/01/2003 | CA2460680A1 Substituted indazole compounds for the treatment of inflammation |
| 04/30/2003 | CN1414962A [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for treatment of central nervous system disorders |
| 04/30/2003 | CN1414848A Prevention of plaque rupure by ACAT inhibitors |
| 04/30/2003 | CN1413990A Epimino substituted benzene derivative |
| 04/29/2003 | US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form |
| 04/29/2003 | US6555569 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| 04/29/2003 | US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders |
| 04/29/2003 | US6555539 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 04/29/2003 | US6555537 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/29/2003 | US6555533 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas |
| 04/29/2003 | CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 04/24/2003 | WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/24/2003 | WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor |
| 04/24/2003 | WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032994A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament |
| 04/24/2003 | WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/24/2003 | WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032903A2 Trisubstituted triazines compounds with antitubulin activity |
| 04/24/2003 | WO2003016282A3 Substituted 1h-dihydropyrazoles, their preparation and use |
| 04/24/2003 | WO2002079147A3 Inhibitors of prenyl-protein transferase |
| 04/24/2003 | WO2002077048A3 Ion-sensitive cationic polymers and fibrous items using same |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078435 Process for the synthesis of a known tetrazol derivative |
| 04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
| 04/24/2003 | US20030078432 Novel benzotriazoles anti-inflammatory compounds |
| 04/24/2003 | US20030078431 Biheterocyclic compounds having high anticoagulant activity, used as inhibitors of factor Xa |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078287 For controlling plant and animal pests |
| 04/24/2003 | US20030078286 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030074833 A hydroxyphenyl-2-benzotriazoles as light stabilizers having ultraviolet light absorbing activity; stabilizer with heat resistance, photostability, oxidation resistance |
| 04/24/2003 | CA2463571A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/23/2003 | EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303498A1 Substituted 2-amino-1,3,5-triazines, and the use thereof as herbicides and plant growth regulators |
| 04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 04/23/2003 | EP1303496A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303307A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/23/2003 | EP1133483B1 Il-5 inhibiting 6-azauracil derivatives |
| 04/23/2003 | EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0906311B1 N-sulfonylimidazoles used as fungicides |
| 04/23/2003 | EP0889881B1 New triazoles as therapeutic agents for fungal infections |
| 04/23/2003 | EP0844998B1 Halobenzimidazoles and their use as microbicides |
| 04/23/2003 | EP0796111B1 In-vivo diagnostic process by near infrared radiation using cyanine dyes |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413203A Method for producing 4-(heteroaryl-methyl)-halogen-1 (2H)-2,3-phthalazmones |
| 04/23/2003 | CN1413198A Methods and compositions utilizing quianzolinones |
| 04/23/2003 | CN1413193A Nitrile derivatives as cathepsin K inhibitors |
| 04/23/2003 | CN1413192A Substituted indole mannich bases |
| 04/23/2003 | CN1413190A EP4 receptor selective agonists in treatment of osteoporosis |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1106400C Antitumor indolophprolocarbazole derivatives |
| 04/23/2003 | CN1106399C Process for preparing sildenafil |
| 04/23/2003 | CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions |
| 04/23/2003 | CN1106383C Estrogenic agents |
| 04/23/2003 | CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552067 EP4 receptor selective agonists in the treatment of osteoporosis |